Viatris (VTRS) EPS (Weighted Average and Diluted) (2019 - 2026)
Viatris (VTRS) recorded quarterly EPS (Weighted Average and Diluted) of $0.15 in Q1 2026, up 150.0% quarter-over-quarter from -$0.3 in Q4 2025, and up 105.88% on a YoY basis from $0.07 in Q1 2025.
Viatris (VTRS) EPS (Weighted Average and Diluted) (2019 - 2026) Analysis & Trends
Viatris' EPS (Weighted Average and Diluted) history runs 8 years deep, the most recent figure standing at $0.15 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 105.88% year-over-year to $0.15; the TTM figure through Mar 2026 stood at -$0.26 (up 91.8% YoY), while the FY2025 annual figure was -$3.0, down 466.04% from the prior year.
- EPS (Weighted Average and Diluted) was $0.15 for Q1 2026 at Viatris, up from -$0.3 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.83 in Q4 2022 to a low of -$2.55 in Q1 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.1 across 5 years, with a median of $0.12 in 2024.
- The sharpest annual moves came in 2022 and 2025: EPS (Weighted Average and Diluted) soared 477.27% in 2022, then slumped 2933.33% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.83 in 2022, then slumped by 175.9% to -$0.63 in 2023, then jumped by 31.75% to -$0.43 in 2024, then soared by 30.23% to -$0.3 in 2025, then jumped by 150.0% to $0.15 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.15 (Q1 2026), -$0.3 (Q4 2025), and -$0.11 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Viatris | - | - | 1.16 Bn | 0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.15 |
| Dec 31, 2025 | -0.30 |
| Sep 30, 2025 | -0.11 |
| Mar 31, 2025 | -2.55 |
| Dec 31, 2024 | -0.43 |
| Sep 30, 2024 | 0.08 |
| Jun 30, 2024 | -0.27 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | -0.63 |
| Sep 30, 2023 | 0.27 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | 0.19 |
| Dec 31, 2022 | 0.83 |
| Sep 30, 2022 | 0.29 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.33 |
| Dec 31, 2021 | -0.22 |
| Sep 30, 2021 | 0.26 |
| Jun 30, 2021 | -0.23 |
| Mar 31, 2021 | -0.86 |